Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma

Journal of Gastrointestinal Cancer

Volumn 42, Issue 2, 2011, Pages 85-92

  Schneider, Günter ^a   Krämer, Oliver H ^b   Schmid, Roland M ^a   Saur, Dieter ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Apoptosis; Cell cycle; HAT; HDAC; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BH3 PROTEIN; CANCER DEVELOPMENT; ETOPOSIDE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 8; I KAPPA B KINASE ALPHA; PROTEIN NOXA; S PHASE KINASE ASSOCIATED PROTEIN 2; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOSENSITIVITY; COMPLEX FORMATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTONE ACETYLATION; HUMAN; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS DUCTAL ADENOCARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR ESCAPE; TUMOR PROMOTION;

ACETYLATION; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; PANCREATIC NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 79956192290     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-011-9257-1     Document Type: Article

References (67)

1. AK Rustgi 2006 The molecular pathogenesis of pancreatic cancer: clarifying a complex circuitry Genes Dev 20 3049 3053 17114578 10.1101/gad.1501106 1:CAS:528:DC%2BD28Xht1Gnt77I (Pubitemid 44790620)
2. G Schneider JT Siveke F Eckel RM Schmid 2005 Pancreatic cancer: basic and clinical aspects Gastroenterology 128 1606 1625 15887154 10.1053/j.gastro.2005. 04.001 1:CAS:528:DC%2BD2MXltlOgtbw%3D (Pubitemid 40692555)
3. AF Hezel AC Kimmelman BZ Stanger N Bardeesy RA Depinho 2006 Genetics and biology of pancreatic ductal adenocarcinoma Genes Dev 20 1218 1249 16702400 10.1101/gad.1415606 1:CAS:528:DC%2BD28XltVyrtb4%3D (Pubitemid 43727584)
4. JB Koorstra SR Hustinx GJ Offerhaus A Maitra 2008 Pancreatic carcinogenesis Pancreatology 8 110 125 18382097 10.1159/000123838 (Pubitemid 351670364)
5. G Schneider RM Schmid 2003 Genetic alterations in pancreatic carcinoma Mol Cancer 2 15 12605716 10.1186/1476-4598-2-15 (Pubitemid 38751482)
6. KP Olive DA Tuveson 2006 The use of targeted mouse models for preclinical testing of novel cancer therapeutics Clin Cancer Res 12 5277 5287 17000660 10.1158/1078-0432.CCR-06-0436 1:CAS:528:DC%2BD28XpvFShs7w%3D (Pubitemid 44497240)
7. KP Olive MA Jacobetz CJ Davidson A Gopinathan D McIntyre D Honess, et al. 2009 Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer Science 324 1457 1461 19460966 10.1126/science.1171362 1:CAS:528:DC%2BD1MXntVSiu7Y%3D
8. S Jones X Zhang DW Parsons JC Lin RJ Leary P Angenendt, et al. 2008 Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 1801 1806 18772397 10.1126/science.1164368 1:CAS:528:DC%2BD1cXhtFCrtLrL
9. MG Rosenfeld VV Lunyak CK Glass 2006 Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response Genes Dev 20 1405 1428 16751179 10.1101/gad.1424806 1:CAS:528:DC%2BD28XlsF2ktLw%3D (Pubitemid 43830648)
10. T Jenuwein CD Allis 2001 Translating the histone code Science 293 1074 1080 11498575 10.1126/science.1063127 1:CAS:528:DC%2BD3MXmtVWltro%3D (Pubitemid 32758077)
11. G Schneider OH Krämer P Fritsche S Schüler RM Schmid D Saur 2010 Targeting histone deacetylases in pancreatic ductal adenocarcinoma J Cell Mol Med 14 1255 1263 19929947 10.1111/j.1582-4934.2009.00974.x 1:CAS:528:DC%2BC3cXhtVGksLvM
12. XJ Yang E Seto 2008 The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men Nat Rev Mol Cell Biol 9 206 218 18292778 10.1038/nrm2346 1:CAS:528:DC%2BD1cXitlGnurk%3D (Pubitemid 351301825)
13. M Haberland RL Montgomery EN Olson 2009 The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat Rev Genet 10 32 42 19065135 10.1038/nrg2485 1:CAS:528:DC%2BD1cXhsFWis7bI
14. S Spange T Wagner T Heinzel OH Krämer 2009 Acetylation of non-histone proteins modulates cellular signalling at multiple levels Int J Biochem Cell Biol 41 185 198 18804549 10.1016/j.biocel.2008.08.027 1:CAS:528:DC%2BD1cXhsVWnu7zP
15. M Buchwald OH Krämer T Heinzel 2009 HDACi-targets beyond chromatin Cancer Lett 280 160 167 19342155 10.1016/j.canlet.2009.02.028 1:CAS:528:DC%2BD1MXmsF2jt7w%3D
16. MA Glozak E Seto 2007 Histone deacetylases and cancer Oncogene 26 5420 5432 17694083 10.1038/sj.onc.1210610 1:CAS:528:DC%2BD2sXovFeku7Y%3D (Pubitemid 47255924)
17. PA Marks WS Xu 2009 Histone deacetylase inhibitors: potential in cancer therapy J Cell Biochem 107 600 608 19459166 10.1002/jcb.22185 1:CAS:528:DC%2BD1MXosFOiurg%3D
18. K Miyake T Yoshizumi S Imura K Sugimoto E Batmunkh H Kanemura, et al. 2008 Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation Pancreas 36 e1 e9 18362831 10.1097/MPA.0b013e31815f2c2a 1:CAS:528:DC%2BD1cXkvVenur0%3D (Pubitemid 351440946)
19. W Wang J Gao XH Man ZS Li YF Gong 2009 Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer Oncol Rep 21 1439 1447 19424621 1:CAS:528:DC%2BD1MXmsVaqtrw%3D
20. P Fritsche B Seidler S Schüler A Schnieke M Göttlicher RM Schmid, et al. 2009 HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA Gut 58 1399 1409 19528037 10.1136/gut.2009.180711 1:CAS:528:DC%2BD1MXhtlSks7bN
21. A Lehmann C Denkert J Budczies AC Buckendahl S Darb-Esfahani A Noske BM Muller M Bahra P Neuhaus M Dietel G Kristiansen W Weichert 2009 High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo BMC Cancer 9 395 19912635 10.1186/1471-2407-9-395
22. M Ouaissi I Sielezneff R Silvestre B Sastre JP Bernard JS Lafontaine, et al. 2008 High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas Ann Surg Oncol 15 2318 2328 18506539 10.1245/s10434-008-9940-z
23. R Hamacher RM Schmid D Saur G Schneider 2008 Apoptotic pathways in pancreatic ductal adenocarcinoma Mol Cancer 7 64 18652674 10.1186/1476-4598-7-64
24. JM Adams S Cory 2007 Bcl-2-regulated apoptosis: mechanism and therapeutic potential Curr Opin Immunol 19 488 496 17629468 10.1016/j.coi.2007.05.004 1:CAS:528:DC%2BD2sXhtFSmu7vN (Pubitemid 47487452)
25. G Häcker A Weber 2007 BH3-only proteins trigger cytochrome c release, but how? Arch Biochem Biophys 462 150 155 17306210 10.1016/j.abb.2006. 12.022 (Pubitemid 46856314)
26. S Schüler P Fritsche S Diersch A Arlt RM Schmid D Saur G Schneider 2010 HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells Mol Cancer 9 80 20398369 10.1186/1476-4598-9-80
27. OH Krämer 2009 HDAC2: a critical factor in health and disease Trends Pharmacol Sci 30 647 655 19892411 10.1016/j.tips.2009.09.007
28. OH Krämer P Zhu HP Ostendorff M Golebiewski J Tiefenbach MA Peters, et al. 2003 The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 EMBO J 22 3411 3420 12840003 10.1093/emboj/cdg315 (Pubitemid 36834871)
29. G Bug M Ritter B Wassmann C Schoch T Heinzel K Schwarz, et al. 2005 Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia Cancer 104 2717 2725 16294345 10.1002/cncr.21589 1:CAS:528:DC%2BD28XptlSktg%3D%3D (Pubitemid 41798282)
30. S Sebens A Arlt H Schäfer 2008 NF-kappaB as a molecular target in the therapy of pancreatic carcinoma Recent Results Cancer Res 177 151 164 18084957 10.1007/978-3-540-71279-4-17 1:CAS:528:DC%2BD1cXhslSjtr8%3D
31. G Schneider D Saur JT Siveke R Fritsch FR Greten RM Schmid 2006 IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression EMBO J 25 3801 3812 16902410 10.1038/sj.emboj.7601259 1:CAS:528:DC%2BD28XovVSqu7o%3D (Pubitemid 44300266)
32. G Schneider R Hamacher S Eser HM Friess RM Schmid D Saur 2008 Molecular biology of pancreatic cancer-new aspects and targets Anticancer Res 28 1541 1550 18630509 1:CAS:528:DC%2BD1cXos1WktLY%3D (Pubitemid 351892927)
33. KI Nakayama K Nakayama 2006 Ubiquitin ligases: cell-cycle control and cancer Nat Rev Cancer 6 369 381 16633365 10.1038/nrc1881 1:CAS:528: DC%2BD28XjslGitb4%3D
34. T Einama Y Kagata H Tsuda D Morita S Ogata S Ueda, et al. 2006 High-level Skp2 expression in pancreatic ductal adenocarcinoma: correlation with the extent of lymph node metastasis, higher histological grade, and poorer patient outcome Pancreas 32 376 381 16670630 10.1097/01.mpa.0000220862.78248.c4 1:CAS:528:DC%2BD28XlsFCqs7w%3D (Pubitemid 43772193)
35. KJ Stanya HY Kao 2009 New insights into the functions and regulation of the transcriptional corepressors SMRT and N-CoR Cell Div 4 7 19383165 10.1186/1747-1028-4-7
36. G Schneider M Reichert D Saur R Hamacher R Fritsch RM Schmid 2007 HDAC3 is linked to cell cycle machinery in MiaPaCa2 cells by regulating transcription of skp2 Cell Prolif 40 522 531 17635519 10.1111/j.1365-2184.2007.00454.x 1:CAS:528:DC%2BD2sXhtVSksLbP (Pubitemid 47063293)
37. GP Gupta J Massague 2006 Cancer metastasis: building a framework Cell 127 679 695 17110329 10.1016/j.cell.2006.11.001 1:CAS:528:DC%2BD28Xht1yqs7rL (Pubitemid 44781029)
38. JP Thiery H Acloque RY Huang MA Nieto 2009 Epithelial-mesenchymal transitions in development and disease Cell 139 871 890 19945376 10.1016/j.cell.2009.11.007 1:CAS:528:DC%2BC3cXksFWltA%3D%3D
39. R Kalluri RA Weinberg 2009 The basics of epithelial-mesenchymal transition J Clin Invest 119 1420 1428 19487818 10.1172/JCI39104 1:CAS:528:DC%2BD1MXntVCjtr0%3D
40. U Cavallaro G Christofori 2004 Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nat Rev Cancer 4 118 132 14964308 10.1038/nrc1276 1:CAS:528:DC%2BD2cXhtlaquro%3D (Pubitemid 38198740)
41. J von Burstin S Eser MC Paul B Seidler M Brandl M Messer, et al. 2009 E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex Gastroenterology 137 361 371 10.1053/j.gastro.2009.04.004 371 e361-365
42. B Hotz M Arndt S Dullat S Bhargava HJ Buhr HG Hotz 2007 Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer Clin Cancer Res 13 4769 4776 17699854 10.1158/1078-0432.CCR- 06-2926 1:CAS:528:DC%2BD2sXptVGmtrY%3D (Pubitemid 47294783)
43. MJ Truty G Lomberk ME Fernandez-Zapico R Urrutia 2009 Silencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signaling J Biol Chem 284 6291 6300 19088080 10.1074/jbc.M807791200 1:CAS:528: DC%2BD1MXisVSkur4%3D
44. A Grzenda G Lomberk JS Zhang R Urrutia 2009 Sin3: master scaffold and transcriptional corepressor Biochim Biophys Acta 1789 443 450 19505602 1:CAS:528:DC%2BD1MXhtV2ksrrK
45. J Massague 2008 TGFbeta in cancer Cell 134 215 230 18662538 10.1016/j.cell.2008.07.001 1:CAS:528:DC%2BD1cXptlaltbk%3D (Pubitemid 352010335)
46. V Ellenrieder 2008 TGFbeta regulated gene expression by Smads and Sp1/KLF-like transcription factors in cancer Anticancer Res 28 1531 1539 18630508 1:CAS:528:DC%2BD1cXos1WktLg%3D (Pubitemid 351892926)
47. K Venkatasubbarao MM Ahmed M Mohiuddin C Swiderski E Lee WR Gower Jr, et al. 2000 Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma Anticancer Res 20 43 51 10769633 1:CAS:528:DC%2BD3cXisl2nsrk%3D (Pubitemid 30189732)
48. H Ijichi A Chytil AE Gorska ME Aakre Y Fujitani S Fujitani, et al. 2006 Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression Genes Dev 20 3147 3160 17114585 10.1101/gad.1475506 1:CAS:528:DC%2BD28Xht1Gnt7%2FP (Pubitemid 44790629)
49. M Goggins M Shekher K Turnacioglu CJ Yeo RH Hruban SE Kern 1998 Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas Cancer Res 58 5329 5332 9850059 1:CAS:528: DyaK1cXotVSkt7g%3D (Pubitemid 28551110)
50. S Zhao K Venkatasubbarao S Li JW Freeman 2003 Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells Cancer Res 63 2624 2630 12750289 1:CAS:528:DC%2BD3sXjsleht7o%3D (Pubitemid 36605205)
51. W Huang S Zhao S Ammanamanchi M Brattain K Venkatasubbarao JW Freeman 2005 Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex J Biol Chem 280 10047 1054 15647279 10.1074/jbc.M408680200 1:CAS:528:DC%2BD2MXit1ektLc%3D (Pubitemid 40395856)
52. SY Roth JM Denu CD Allis 2001 Histone acetyltransferases Annu Rev Biochem 70 81 120 11395403 10.1146/annurev.biochem.70.1.81 1:CAS:528: DC%2BD3MXlsVehtrc%3D (Pubitemid 32662206)
53. R Marmorstein RC Trievel 2009 Histone modifying enzymes: structures, mechanisms, and specificities Biochim Biophys Acta 1789 58 68 18722564 1:CAS:528:DC%2BD1cXhsVOis7bJ
54. BR Keppler TK Archer 2008 Chromatin-modifying enzymes as therapeutic targets-part 2 Expert Opin Ther Targets 12 1457 1467 18851700 10.1517/14728222.12.11.1457
55. ST Mees WA Mardin C Wendel N Baeumer E Willscher N Senninger, et al. 2010 EP300-a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas Int J Cancer 126 114 124 19569050 10.1002/ijc.24695 1:CAS:528:DC%2BD1MXhsVamtL7L
56. A Esquela-Kerscher FJ Slack 2006 Oncomirs-microRNAs with a role in cancer Nat Rev Cancer 6 259 269 16557279 10.1038/nrc1840 1:CAS:528: DC%2BD28XivVyqtrs%3D
57. SA Gayther SJ Batley L Linger A Bannister K Thorpe SF Chin, et al. 2000 Mutations truncating the EP300 acetylase in human cancers Nat Genet 24 300 303 10700188 10.1038/73536 1:CAS:528:DC%2BD3cXhvFaqtL4%3D (Pubitemid 30132203)
58. A König T Linhart K Schlengemann K Reutlinger J Wegele G Adler, et al. 2009 NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells Gastroenterology 138 1189-99 e1 e2
59. M Eilers RN Eisenman 2008 Myc's broad reach Genes Dev 22 2755 2766 18923074 10.1101/gad.1712408 1:CAS:528:DC%2BD1cXht12ht7zE
60. C Schleger C Verbeke R Hildenbrand H Zentgraf U Bleyl 2002 c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance Mod Pathol 15 462 469 11950922 10.1038/modpathol.3880547 1:STN:280:DC%2BD383hsVGhsQ%3D%3D (Pubitemid 34326956)
61. YJ Li ZM Wei YX Meng XR Ji 2005 Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis World J Gastroenterol 11 2117 2123 15810077 1:CAS:528:DC%2BD2MXktlWrsbc%3D
62. EH Mahlamaki M Barlund M Tanner L Gorunova M Hoglund R Karhu, et al. 2002 Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer Genes Chromosom Cancer 35 353 358 12378529 10.1002/gcc.10122 1:CAS:528:DC%2BD38XptVGis70%3D (Pubitemid 35246993)
63. C Schild M Wirth M Reichert RM Schmid D Saur G Schneider 2009 PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells Mol Carcinog 48 1149 1158 19603422 10.1002/mc.20569 1:CAS:528:DC%2BD1MXhsVyls7vL
64. M Buchholz A Schatz M Wagner P Michl T Linhart G Adler, et al. 2006 Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway EMBO J 25 3714 3724 16874304 10.1038/sj.emboj.7601246 1:CAS:528:DC%2BD28XnvVGlsLk%3D (Pubitemid 44264881)
65. MF Fraga E Ballestar A Villar-Garea M Boix-Chornet J Espada G Schotta, et al. 2005 Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer Nat Genet 37 391 400 15765097 10.1038/ng1531 1:CAS:528:DC%2BD2MXislCmurg%3D
66. DB Seligson S Horvath T Shi H Yu S Tze M Grunstein, et al. 2005 Global histone modification patterns predict risk of prostate cancer recurrence Nature 435 1262 1266 15988529 10.1038/nature03672 1:CAS:528:DC%2BD2MXls1Ontbg%3D (Pubitemid 40943093)
67. A Manuyakorn R Paulus J Farrell NA Dawson S Tze G Cheung-Lau, et al. 2010 Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704 J Clin Oncol 28 1358 1365 20142597 10.1200/JCO.2009.24.5639 1:CAS:528:DC%2BC3cXksFSqur4%3D